Blood markers could help identify head and neck cancer risk early

Swedish researchers found that certain metabolic compounds in blood can predict who will develop head and neck cancer, potentially enabling earlier diagnosis. The discovery could reshape screening protocols and help pharmaceutical companies develop new prevention strategies targeting at-risk populations.

Originaltitel: Blood metabolic biomarkers and the risk of head and neck cancer: An epidemiological study in the Swedish AMORIS Cohort